Upexi (UPXI) Competitors $12.77 +2.89 (+29.25%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$12.30 -0.47 (-3.68%) As of 04:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock UPXI vs. PYRGF, ANRO, ASRT, PDSB, RPTX, IMMX, MGX, ADVM, APLT, and GANXShould you be buying Upexi stock or one of its competitors? The main competitors of Upexi include PyroGenesis Canada (PYRGF), Alto Neuroscience (ANRO), Assertio (ASRT), PDS Biotechnology (PDSB), Repare Therapeutics (RPTX), Immix Biopharma (IMMX), Metagenomi (MGX), Adverum Biotechnologies (ADVM), Applied Therapeutics (APLT), and Gain Therapeutics (GANX). These companies are all part of the "pharmaceutical products" industry. Upexi vs. PyroGenesis Canada Alto Neuroscience Assertio PDS Biotechnology Repare Therapeutics Immix Biopharma Metagenomi Adverum Biotechnologies Applied Therapeutics Gain Therapeutics PyroGenesis Canada (NASDAQ:PYRGF) and Upexi (NASDAQ:UPXI) are both small-cap industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, community ranking, media sentiment and profitability. Does the MarketBeat Community believe in PYRGF or UPXI? Upexi received 3 more outperform votes than PyroGenesis Canada when rated by MarketBeat users. CompanyUnderperformOutperformPyroGenesis CanadaN/AN/AUpexiOutperform Votes342.86% Underperform Votes457.14% Which has better valuation & earnings, PYRGF or UPXI? PyroGenesis Canada has higher earnings, but lower revenue than Upexi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M7.05-$21.12M-$0.02-17.25Upexi$16.56M1.10-$23.66MN/AN/A Which has more risk and volatility, PYRGF or UPXI? PyroGenesis Canada has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, Upexi has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Is PYRGF or UPXI more profitable? Upexi has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% N/A -60.81% Upexi N/A N/A N/A Do insiders and institutionals have more ownership in PYRGF or UPXI? 0.0% of PyroGenesis Canada shares are owned by institutional investors. Comparatively, 5.7% of Upexi shares are owned by institutional investors. 47.7% of PyroGenesis Canada shares are owned by company insiders. Comparatively, 31.6% of Upexi shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer PYRGF or UPXI? In the previous week, PyroGenesis Canada and PyroGenesis Canada both had 2 articles in the media. Upexi's average media sentiment score of 0.69 beat PyroGenesis Canada's score of 0.31 indicating that Upexi is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Upexi 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryUpexi beats PyroGenesis Canada on 6 of the 10 factors compared between the two stocks. Get Upexi News Delivered to You Automatically Sign up to receive the latest news and ratings for UPXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPXI vs. The Competition Export to ExcelMetricUpexiMedicinals & botanicals IndustryBusiness SectorNASDAQ ExchangeMarket Cap$18.21M$1.16B$16.37B$8.39BDividend YieldN/AN/A2.49%4.10%P/E RatioN/A10.4332.0219.71Price / Sales1.108.64266.82117.39Price / CashN/A10.4031.5334.62Price / Book4.481.485.284.50Net Income-$23.66M-$54.34M$195.26M$248.18M7 Day Performance33.30%2.12%-0.97%0.20%1 Month Performance41.89%9.10%14.33%12.37%1 Year Performance35.88%-35.75%14.94%7.04% Upexi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPXIUpexi0.7667 of 5 stars$12.77+29.3%N/A+36.0%$18.21M$16.56M0.00130Earnings ReportPYRGFPyroGenesis CanadaN/A$0.33+1.9%N/A-24.5%$60.67M$9.14M-5.5290Gap UpANROAlto Neuroscience1.7323 of 5 stars$2.34+5.4%$15.40+558.1%-77.4%$60.10MN/A-0.92N/APositive NewsAnalyst RevisionASRTAssertio2.0136 of 5 stars$0.62+0.9%$2.75+346.9%-32.8%$58.94M$124.96M-0.8420Analyst ForecastGap UpPDSBPDS Biotechnology1.5773 of 5 stars$1.29+7.5%$9.00+597.7%-55.6%$58.92MN/A-1.1120Gap UpRPTXRepare Therapeutics3.0827 of 5 stars$1.36flat$4.50+230.9%-61.2%$58.33M$53.48M-0.68180Positive NewsIMMXImmix Biopharma1.9484 of 5 stars$2.09flat$7.00+234.9%-9.1%$58.17MN/A-2.469News CoveragePositive NewsMGXMetagenomi1.3493 of 5 stars$1.55+2.6%$14.75+851.6%-76.8%$57.94M$52.30M-0.59236Gap UpADVMAdverum Biotechnologies3.7742 of 5 stars$2.71-3.6%$26.60+881.5%-71.1%$56.62M$1M-0.45190Analyst RevisionHigh Trading VolumeAPLTApplied Therapeutics4.0295 of 5 stars$0.46+15.7%$6.10+1,218.6%-91.1%$56.59M$455,000.00-0.2930News CoverageAnalyst RevisionGANXGain Therapeutics1.9727 of 5 stars$1.92-1.0%$8.20+327.1%-27.6%$56.50M$50,000.00-1.7520News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies PYRGF Alternatives ANRO Alternatives ASRT Alternatives PDSB Alternatives RPTX Alternatives IMMX Alternatives MGX Alternatives ADVM Alternatives APLT Alternatives GANX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPXI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Upexi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Upexi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UPXI Stock Free UPXI Stock Alerts